Max Uniorange Pharma (India) Private Limited

Max Uniorange Pharma (India) Private Limited - trading in Kochi, Kerala, India. FY 2026 financials & compliance.
CIN U24233KL2009PTC024373 Incorporated 26 June 2009 ROC Ernakulam HQ Kochi, Kerala, India
Pending Strike Off Private Limited Company trading
Revenue · FY 2017
₹23.01 Lakh
Latest filing
Net loss · FY 2017
₹2.99 Lakh
Net margin -13%
EBITDA · FY 2017
-₹54,538
EBITDA margin -2.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
4
As per MCA filings
GST registrations
1
None active

About Max Uniorange Pharma (India) Private Limited

Data last updated:

Max Uniorange Pharma (India) Private Limited is a private limited company based in Kochi, Kerala, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 26 June 2009.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24233KL2009PTC024373. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Vijayan Praveen (Whole-Time Director) and Thomas Varkey Padingare Chempanal (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 3/335 – K 2nd Floor Jogeo Building P. T. Road Kakkanad, Kochi, Kerala, India – 682021.

As per the financials filed for FY 2017, the company reported a revenue of ₹23.01 Lakh. For the same year it recorded a net loss of ₹2.99 Lakh (net margin -13%) and EBITDA of -₹54,538 (EBITDA margin -2.4%).

Company details

CIN U24233KL2009PTC024373
Registration Number 024373
Incorporation Date 26 June 2009
ROC Ernakulam
Listing Status Unlisted
Company Status Under Process of Striking Off
Compliance Status Active Compliant

Contact details

Max Uniorange Pharma (India) Private Limited's registered office is in Kochi, Kerala. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    3/335 – K 2nd Floor Jogeo Building P. T. Road Kakkanad, Kochi, Kerala, India – 682021
  • Industry
    Trading, Other Wholesale, Wholesale

To see the full contact details of Max Uniorange Pharma (India) Private Limited, buy the company report.

Comprehensive company report
Max Uniorange Pharma (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Max Uniorange Pharma (India) Private Limited

FY 2023 filings available

Max Uniorange Pharma (India) Private Limited reported revenue of ₹23.01 Lakh for FY 2017.

Revenue · FY 2017
₹23.01 Lakh
Net loss · FY 2017
₹2.99 Lakh margin -13%
EBITDA · FY 2017
-₹54,538 margin -2.4%

Financial Statement Summary

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹23.01 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹54,538
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.99 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin-2.4%
Net Profit Margin-13%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Max Uniorange Pharma (India) Private Limited, buy the company report.

Board of directors of Max Uniorange Pharma (India) Private Limited

Max Uniorange Pharma (India) has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vijayan PraveenWhole-Time Director26 Jun 200917 Years 4 MonthsCurrent
Thomas Varkey Padingare ChempanalWhole-Time Director26 Jun 200917 Years 4 MonthsCurrent
John Thottumkal ThomasWhole-Time Director26 Jun 200917 Years 4 MonthsCurrent
Abdulrahim Aboobacker PallimuttatheWhole-Time Director26 Jun 200917 Years 4 MonthsCurrent

Auditor

Max Uniorange Pharma (India) Private Limited is audited by AYYAR AND CHERIAN for the financial year 2017.

Auditor firmFinancial yearFirm registration number
AYYAR AND CHERIANFY 2017000284S

Shareholding

The shareholding of Max Uniorange Pharma (India) Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Max Uniorange Pharma (India) Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Max Uniorange Pharma (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Max Uniorange Pharma (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Max Uniorange Pharma (India) Private Limited, buy the company report.

Recent activity

Max Uniorange Pharma (India) Private Limited has 16 board changes on record since 2009: 10 appointments and 6 cessations. The latest: Arunraj Rajasekhar ceased to be Whole-Time Director on 12 Apr 2019.

AGM
Max Uniorange Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Max Uniorange Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam.
Ceased
Arunraj Rajasekhar ceased to be Whole-Time Director.
Ceased
Praddeep Palasseri Kalathil ceased to be Whole-Time Director.
Ceased
Putharadathu Narayanan Bhavanendranathan Nair ceased to be Whole-Time Director.
Ceased
Raghunandan Govinda Menon ceased to be Director.
Ceased
Rajeswar Dayal Chandrasekharan Nair ceased to be Whole-Time Director.
Ceased
Anil Kumar Nadukandi ceased to be Director.
Appointed
Praddeep Palasseri Kalathil was appointed as Whole-Time Director.
Appointed
Abdulrahim Aboobacker Pallimuttathe was appointed as Whole-Time Director.
Appointed
Anil Kumar Nadukandi was appointed as Director.
Appointed
Arunraj Rajasekhar was appointed as Whole-Time Director.

7 earlier events are in the company report.

Frequently asked questions

Max Uniorange Pharma (India) is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.

Max Uniorange Pharma (India) is a company pending strike off, currently registered as a private limited company based in Kochi, Kerala, India. The company works in other wholesale, within the trading industry. It was incorporated on 26 June 2009 and is registered under CIN U24233KL2009PTC024373. The company may be struck off soon - caution is advised.

The compliance status of Max Uniorange Pharma (India) is compliant as of 30 July 2026.

Max Uniorange Pharma (India) has 4 current directors:

The CIN (Corporate Identification Number) of Max Uniorange Pharma (India) is U24233KL2009PTC024373. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Max Uniorange Pharma (India) was incorporated on 26 June 2009. It is registered with the Registrar of Companies, Ernakulam.

The registered office of Max Uniorange Pharma (India) is at 3335 – K 2nd Floor Jogeo Building P. T. Road Kakkanad, Kochi, Kerala, India – 682021.

The latest financial statements of Max Uniorange Pharma (India) on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.

No. Max Uniorange Pharma (India) has 1 GST registration on record and it is cancelled or inactive.

Max Uniorange Pharma (India) operates in the trading industry, in the other wholesale segment.